Details for New Drug Application (NDA): 215087
✉ Email this page to a colleague
The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 215087
Tradename: | DAPSONE |
Applicant: | Padagis Israel |
Ingredient: | dapsone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215087
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TOPICAL | Strength | 5% | ||||
Approval Date: | Oct 31, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription